Return to the top


  • 18 April 2021

    Focal therapy using HIFU or cryotherapy has similar outcomes to prostatectomy

    A recent propensity score matched study published in Prostate Cancer Prostate Diseases (Nature) has shown results from the UK that over 6-7 years, the cancer control from focal therapy (HIFU or cryotherapy) is similar to radical prostatectomy. Further details can … Continue reading

  • 18 April 2021

    Prostagram for screening prostate cancer

    The IP1-PROSTAGRAM study was led by Professor Ahmed and published in the prestigious JAMA Oncology journal. Further details can be found in this News article.

  • 9 January 2019

    Focal cryotherapy in treating prostate cancer

    BOOK ONLINE Professor Ahmed leads a study in the UK showing excellent functional outcomes and cancer control in men with prostate cancer treated with focal cryotherapy.

  • 5 December 2018

    Image fusion targeted biopsy is highly accurate

    BOOK ONLINE A study led by Professor Ahmed has shown that image-fusion targeted biopsies are highly accurate in detecting prostate cancer The SmartTarget trial

  • 27 June 2018

    Focal HIFU therapy in treatment of prostate cancer: a UK Multicentre series

    In this multicentre study of 625 patients undergoing focal therapy using high-intensity focused ultrasound (HIFU), failure-free survival, metastasis-free survival, cancer-specific survival, and overall survival were 88%, 98%, 100%, and 99%, respectively. Urinary incontinence (any pad use) was 2% and erectile function 15% overall although for men with good baseline function this was 5%. Focal HIFU therapy for patients with clinically significant prostate cancer that has not spread has a low probability of side effects and is effective at 5 yr. Continue reading

  • 2 February 2017

    PROMIS Trial of MRI for Prostate Cancer Detection

    BOOK ONLINE Ground-breaking study shows that MRI before prostate is much more accurate than prostate biopsy at ruling out and ruling in important prostate cancer. Professor Ahmed was co-Chief Investigator in the study with Professor Emberton. Ahmed HU, El-Shater Bosaily … Continue reading

  • 4 November 2015

    The index lesion and the origin of prostate cancer.

    Genomic “signatures” of prostate cancer and its metastases suggest that the latter are all derived from a single clone in the prostate gland. Continue reading

  • 4 November 2015

    Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study.


  • 4 November 2015

    Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy?